Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bone Neoplasms × ridaforolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Bone Neoplasms 1

Interventions

Ibandronic Acid 4 Zoledronic Acid 3 Tranexamic Acid 2 ridaforolimus 1 dinutuximab 1 Sodium Pertechnetate Tc 99m 1 Sodium Chloride 1 Neutrons 1 Fluoridation 1 Fibrin Tissue Adhesive 1 Diathermy 1 Denosumab 1 Cyproheptadine 1 Cefazolin 1 Captopril 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00538239 2015-02-13

SUCCEED

Merck Sharp & Dohme LLC

Phase 3 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡